Your session is about to expire
← Back to Search
VitalCare Platform
Remote Patient Monitoring for Heart Failure (FAST-RPM-HF Trial)
N/A
Waitlist Available
Research Sponsored by Saint Luke's Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
New York Heart Association Class II or III congestive HF symptoms
A clinical diagnosis of heart failure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month
Awards & highlights
FAST-RPM-HF Trial Summary
This trial will be the first to study the effect of remote patient monitoring with the VitalCare platform on outcomes of ambulatory heart failure patients.
Who is the study for?
This trial is for adults with heart failure who've been hospitalized for it within the last year, can use a smartphone or tablet, and speak English. It's not for pregnant individuals, those awaiting a heart transplant, with severe kidney disease or very poor heart function (LVEF < 35%), or have certain implanted cardiac devices.Check my eligibility
What is being tested?
The study tests the VitalCare platform's ability to monitor heart failure patients remotely. It aims to see if this technology improves patient engagement and reduces hospital visits due to worsening heart failure.See study design
What are the potential side effects?
Since this trial involves remote monitoring rather than medication, traditional side effects are not expected. However, there may be privacy concerns or stress related to constant health tracking.
FAST-RPM-HF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have moderate heart failure symptoms.
Select...
I have been diagnosed with heart failure.
Select...
I was hospitalized for heart failure symptoms within the last year.
FAST-RPM-HF Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Compliance with monitoring protocol
Secondary outcome measures
Heart failure hospitalizations, emergency room visits for Heart Failure as compared to prior to trial enrollment
Patient engagement as measured by Patient Activation Measure
FAST-RPM-HF Trial Design
1Treatment groups
Experimental Treatment
Group I: InterventionalExperimental Treatment1 Intervention
All patients receive the VitalCare platform with a tablet computer, an Eko Duo device, a weight scale, a blood pressure cuff, a pulse oximeter
Find a Location
Who is running the clinical trial?
Saint Luke's Health SystemLead Sponsor
41 Previous Clinical Trials
12,916 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are waiting for a heart transplant.I have moderate heart failure symptoms.My heart failure symptoms are mild or very severe.I have been diagnosed with heart failure.My kidneys are in the final stage of failure.Your heart is not pumping enough blood.I'm not sure what you're asking. Can you provide more context or clarify your question?You have a permanent heart device like a pacemaker, defibrillator, or other implanted heart monitoring device.You have a left ventricular assist device (LVAD).I was hospitalized for heart failure symptoms within the last year.
Research Study Groups:
This trial has the following groups:- Group 1: Interventional
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are individuals over the age of 18 eligible for participation in this clinical research?
"This research project is open to all participants who have reached the age of majority and are yet to turn 80."
Answered by AI
Who is the ideal demographic for participating in this medical research?
"Patients between the ages of 18 and 80 suffering from congestive heart failure are eligible to participate in this clinical trial. The research team is looking for 30 such individuals to join the study."
Answered by AI
Are there still openings for participants in this experiment?
"According to the clinicaltrials.gov database, this particular trial is no longer seeking additional participants - it was first posted on August 1st 2023 and last updated June 8th 2023. Nevertheless, there are currently 732 other studies actively recruiting new enrollees."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger